Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanara MedTech Inc. Director's Dealing 2015

Jun 23, 2015

33339_dirs_2015-06-23_1a3172bd-4815-433d-8eb0-aac86dff1c96.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2015-05-18

Reporting Person: HOWELL S ODEN JR (Director, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Series C Preferred Stock 16535 Direct
Series C Preferred Stock 2959 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant $0.15 2017-07-23 Common Stock (250000) Direct
Convertible Secured Subordinated Promissory Note $0.7 2018-06-15 Series C Preferred Stock () Indirect

Footnotes

F1: This warrant may be exercised, in whole or in part, on or prior to July 23, 2017.

F2: This Note provides that the remaining balance may be converted, at the option of the Lender, into shares of preferred stock at any time prior to either (i) the third anniversary of the date of the Note (such date being June 15, 2018), or (ii) the occurrence of an Event of Default.